HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Whitehead, B. F. Articles by Elliott, M. J. Search for Related Content PubMed PubMed Citation Articles by Whitehead, B. F. Articles by Elliott, M. J.

European Journal of Cardio-Thoracic Surgery, Vol 9, 1-6, Copyright © 1995 by European Association for Cardio-thoracic Surgery

ARTICLES

Results of heart-lung transplantation in children with cystic fibrosis

BF Whitehead, PG Rees, K Sorensen, C Bull, J Fabre, MR de Leval and MJ Elliott
Cardiothoracic Unit, Hospital for Sick Children, London, UK.

Children with cystic fibrosis represent the largest group referred for, and undergoing, heart-lung transplantation at our institute. Between June 1988 and July 1993, 76 patients were accepted for transplantation, of whom 25 were transplanted, while a further 36 died waiting. Those transplanted ranged from 5-18 years of age and included 13 males and 12 females. Organs were used from donors matched by ABO blood group, size and cytomegalovirus (CMV) status. Post-transplant maintenance immunosuppression comprised cyclosporin A, azathioprine and prednisolone. Anti-thymocyte globulin and high dose methylprednisolone were given peri-operatively and for acute rejection episodes. Actuarial survival was 67% at 1 year, 61% at 2 years and 54% at 3 years. Obliterative bronchiolitis (OB) has occurred in 13 patients (52%) and was the major cause of mortality and morbidity. In three patients, OB was associated with the development of tracheal anastomotic stenosis. Other complications included diabetes mellitus (n = 9), pancreatitis (n = 1) and hypertension (n = 8). Despite these problems, those surviving the first year post-transplant showed a mean FEV1 of 71% (compared to 29% pre-transplant) and enjoyed an overall improved quality of life.

This article has been cited by other articles:

				A. G. KADITIS, M. GONDOR, P. A. NIXON, S. WEBBER, R. J. KEENAN, R. KAYE, and G. KURLAND Airway Complications Following Pediatric Lung and Heart-Lung Transplantation Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 301 - 309. [Abstract] [Full Text]

				K. Wiebe, Th. Wahlers, W. Harringer, H.v.d. Hardt, H. Fabel, and A. Haverich Lung transplantation for cystic fibrosis - a single center experience over 8 years Eur. J. Cardiothorac. Surg., August 1, 1999; 14(2): 191 - 196. [Abstract] [Full Text] [PDF]

				A. Khaghani, F. Santini, C. M. Dyke, O. Onuzu, R. Radley-Smith, and M. H. Yacoub HETEROTOPIC CARDIAC TRANSPLANTATION IN INFANTS AND CHILDREN J. Thorac. Cardiovasc. Surg., June 1, 1997; 113(6): 1042 - 1049. [Abstract] [Full Text]

				I M Balfour-Lynn, I Martin, B F Whitehead, P G Rees, M J Elliott, and M R de Leval Heart-lung transplantation for patients under 10 with cystic fibrosis Arch. Dis. Child., January 1, 1997; 76(1): 38 - 40. [Abstract] [Full Text]